首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   62595篇
  免费   4404篇
  国内免费   1449篇
耳鼻咽喉   169篇
儿科学   1437篇
妇产科学   774篇
基础医学   4577篇
口腔科学   547篇
临床医学   7748篇
内科学   19741篇
皮肤病学   297篇
神经病学   1028篇
特种医学   941篇
外国民族医学   1篇
外科学   7382篇
综合类   9799篇
现状与发展   3篇
预防医学   3349篇
眼科学   146篇
药学   5688篇
  53篇
中国医学   3198篇
肿瘤学   1570篇
  2024年   120篇
  2023年   1118篇
  2022年   1979篇
  2021年   2839篇
  2020年   2724篇
  2019年   2249篇
  2018年   2152篇
  2017年   2138篇
  2016年   2144篇
  2015年   2300篇
  2014年   4470篇
  2013年   4590篇
  2012年   3523篇
  2011年   4171篇
  2010年   3153篇
  2009年   3100篇
  2008年   3026篇
  2007年   3090篇
  2006年   2784篇
  2005年   2506篇
  2004年   1937篇
  2003年   1703篇
  2002年   1386篇
  2001年   1292篇
  2000年   958篇
  1999年   855篇
  1998年   684篇
  1997年   637篇
  1996年   604篇
  1995年   519篇
  1994年   532篇
  1993年   370篇
  1992年   330篇
  1991年   327篇
  1990年   283篇
  1989年   288篇
  1988年   273篇
  1987年   193篇
  1986年   168篇
  1985年   170篇
  1984年   151篇
  1983年   79篇
  1982年   103篇
  1981年   86篇
  1980年   73篇
  1979年   72篇
  1978年   52篇
  1977年   40篇
  1976年   43篇
  1974年   17篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
山莨菪碱防治甘油所致急性肾功能衰竭的实验研究   总被引:2,自引:0,他引:2  
在129只SD大鼠的实验中动态观察了山莨菪碱对甘油所致急性肾功能衰竭时不同时期的Bcr,BUN,pH病理改变及死亡率的影响,结果表明:山莨菪碱能降低ARF第5天大鼠死亡率以及Bcr,BUN水平。改善病理损害,对ARF起到预防及治疗效果,山莨菪碱的预防效果优于治疗效果,预防是ARF防治的关键,但山莨菪碱在治疗过程中要引起“冲刷综合征”导致洗脱性酸中毒,应引起注意。  相似文献   
122.
Treatment of rat heart grafts with PUVA, the combination of the photosensitizer 8-methoxypsoralen and longwave ultraviolet light, leads to a prolonged transplant survival in allogeneic recipients. A PUVA treatment of the recipient rats, performed for 7 consecutive days after transplantation, prolonged graft survival even more effectively. This may be due to the systemic immunomodulatory effects of PUVA in the recipient. One of the mediators is urocanic acid, which is transformed by ultraviolet light in the skin from its trans- to the cis-isomer, which, in turn, acts as a mediator on the immune system. An injection of cisurocanic acid into graft recipients for 7 consecutive days after transplantation resulted in prolonged graft survival; in 40% of the rats, permanent graft acceptance was observed. The significance of these results for clinical organ transplantation is discussed.  相似文献   
123.
Renal and urological anomalies in Down syndrome (DS) have received little attention compared with the nephrourological findings described in other chromosomal abnormalities. Renal hypoplasia, hydroureteronephrosis, ureterovesical and ureteropelvic junction obstruction, and vesicoureteral reflux, but not posterior urethral valves, have been associated with DS. We report the occurrence of posterior urethral valves in three male infants with DS at a single institution. All had multiple urological procedures for correction or palliation of obstruction. Children with DS may have an increased risk for developing posterior urethral valves and obstructive uropathy. Furthermore, they may also develop chronic renal failure secondary to posterior urethral valves. Therefore, we suggests that infants with DS be screened with ultrasonography for renal and urological abnormalities early in life and, if abnormal, a contrast voiding cystourethrogram be performed to rule out posterior urethral valves or other bladder or urethral abnormalities. A review of the renal and urological anomalies in DS reported in the literature since 1960 is presented.  相似文献   
124.
We have devised assays to detect both circulating alloantibodies to platelets (indirect assay) and platelet-association IgG and IgM (direct assay) using a flow cytometric technique. A variety of patients with immune thrombocytopenia were studied. Employment of a confocal lens in the flow cytometer increased the discrimination power of the instrument. Patients with autoimmune thrombocytopenia (idiopathic thrombocytic purpura [ITP], systemic lupus erythematosus (SLE), lymphoma, leukemia, and drug-induced thrombocytopenia showed a significant increase in platelet-associated antibody. Circulating antibodies to platelets (alloantibodies) were demonstrated in cases of platelet refractoriness and neonatal isoimmune purpura. Day-today precision of the assays ranged from 3% to 6% (coefficient of variation). No interference was shown in the presence of hemoglobin (5 g/L), triglycerides (10 g/L), or polyclonal and monoclonal immunoglobulinemia (50 g/L: IgG, IgA, IgM). The sensitivity of the direct assay was 500 attograms of IgG or IgM platelet.  相似文献   
125.
126.
1. The effects of graded treadmill exercise on renal blood flow (RBF) were examined in seven rabbits, in which congestive heart failure (CHF) was produced by the administration of doxorubicin, 1 mg/kg, twice weekly for 8 weeks, and in seven controls. A third group of five rabbits underwent doxorubicin treatment with the addition of surgical section of the left renal sympathetic nerve. 2. During submaximal exercise, there was a small reduction in RBF in controls, which was greatly exaggerated in CHF. 3. In both control and heart failure rabbits, there was a precipitous fall in RBF as exercise fatigue developed. 4. Renal sympathectomy ablated these changes in RBF during exercise. 5. It is concluded that in heart failure there is an exaggerated, sympathetically mediated, diversion of blood flow away from the kidney. The onset of exercise fatigue in both normal and heart failure rabbits is accompanied by a marked intensification of this process.  相似文献   
127.
目的 观察方格星虫提取物对y射线损伤雄性小鼠免疫器官及生殖器官的保护作用.方法 将50只雄性小鼠随机分为正常对照组、模型组及低[0.5g/(kg·d)]、中[1.0g/(kg·d)]、高[2.0g/(kg·d)]3个剂量方格星虫提取物组,每天灌胃给药1次,给药剂量为2.0 mL/kg,灌胃2周后,除正常对照组外,各组均以剂量率为0.83 Gy/h的60Co γ射线进行1次全身照射,照射剂量为5 Gy.于辐照前1 d,辐照后第3天、第14天测定小鼠体重、外周血白细胞数,辐照后第14天测定小鼠胸腺指数、脾指数、骨髓有核细胞计数、睾丸重量指数、精子总数及精子畸形率.结果 方格星虫提取物可使辐照后第3天3个剂量组小鼠外周血白细胞数明显高于模型组(P<0.05),辐照后第14天3个剂量组小鼠的胸腺指数及脾指数明显高于模型组(P<0.05),低、中剂量组小鼠的骨髓有核细胞数显著高于模型组(P<0.05),高剂量组小鼠骨髓有核细胞数显著高于模型组(P<0.01),中、高剂量组睾丸重量指数、精子总数明显高于模型组(P<0.05),中、高剂量组的精子畸形率显著低于模型组(P<0.01).结论 方格星虫提取物对辐射损伤小鼠的免疫器官及生殖器官具有一定的保护作用.  相似文献   
128.
重组人红细胞生成素治疗肾性贫血的临床分析   总被引:1,自引:0,他引:1  
目的 观察重组人红细胞生成素 (RhEPO)对肾性贫血的治疗作用。方法 根据使用EPO剂量的不同将 39例慢性肾衰竭并血液透析病人分成 4组 ,观察治疗后 2、4、12个月时与治疗前 (0月 )相比红细胞数 (RBC)、红细胞比积 (Hct)及血红蛋白含量 (Hb)的变化。结果  2 4例使用EPO10 0 - 15 0IU/ (kg·w) (6 0 0 0IU/w - 90 0 0IU/w) ,治疗后RBC、Hct、Hb较治疗前有显著升高 (P≤ 0 .0 0 1) ;5例使用EPO5 0IU/ (kg·w) (30 0 0IU/w) +间断输血患者 ,其RBC、Hct、Hb升高不显著 ;10例不用EPO而单纯输血患者 ,其RBC、Hct、Hb无明显变化 (P >0 .0 5 )。结论 EPO能较好地纠正肾性贫血 ;单纯输血不能治疗肾性贫血  相似文献   
129.
We selected a group of male dialysis patients complaining of sexual dysfunction in whom penile vascular insufficiency and drug-induced impotence had been excluded. Monitoring of nocturnal penile tumescence was used to confirm organic disturbance. Patients with normal serum prolactin concentrations (n = 18) had significantly lower serum zinc values than normal controls (P less than 0.001) and were entered in a 6-month double-blind study comparing oral zinc acetate with placebo. Patients with elevated prolactin concentrations (n = 8) were entered in a 3-month double-blind crossover study comparing oral pergolide mesylate with placebo. In the zinc study, serum zinc concentrations increased (P less than 0.05) in the zinc-treated but not the placebo-treated group. One of nine patients receiving zinc reported improved sexual function, as did two of nine patients receiving placebo. There were no significant changes in sperm counts, nocturnal penile tumescence, testosterone, sex hormone binding globulin or gonadotrophin concentrations in either treatment group. In the pergolide study, serum prolactin values decreased (P less than 0.01) in the pergolide but not in the placebo treatment period. One patient reported improved sexual function during the pergolide treatment period and two during the placebo period. There were no significant changes in sperm counts, nocturnal penile tumescence, testosterone, sex hormone binding globulin or gonadotrophin concentrations after pergolide. These studies show no benefit of zinc or pergolide compared with placebo in the treatment of uraemic impotence.  相似文献   
130.
β受体阻滞在心血管疾病中的临床应用研究进展   总被引:4,自引:0,他引:4  
李秀真  陈显德  辛怀玉 《医学综述》2006,12(16):1015-1018
依据国内外的临床研究和循证医学分析,对β受体阻滞剂在心血管疾病方面的合理应用以及适应证,给药方法进行循证性举证,提示β受体阻滞剂可明显改善心血管疾病的临床预后,除非有禁忌证及不能酎受者,β受体阻滞剂应作为心血管疾病的常规治疗病物广泛应用于心血管疾病。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号